Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

762
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

802
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

812
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

485
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
485
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

837
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
837
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

968
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
968

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Achondroplasia management in the era of targeted therapies: a meta-analysis of C-type natriuretic peptide analogs.

Journal of the Endocrine Society·2026
Same author

Safety and efficacy of lorundrostat, an aldosterone synthase inhibitor, in patients with uncontrolled hypertension: A systematic review and meta-analysis.

Medicine·2026
Same author

Anti-Obesity Pharmacotherapy and Emerging Multimodal Interventions for Obstructive Sleep Apnea.

Chronic diseases and translational medicine·2026
Same author

Type 1 Diabetes and Cardiovascular Risk: The Current Management Strategies.

Reviews in cardiovascular medicine·2026
Same author

Symbiosis of international medical graduates in the NHS.

BMJ (Clinical research ed.)·2026
Same author

From Induction to Maintenance? Rethinking GLP-1-Based Obesity Pharmacotherapy in the Era of Oral Agents.

Diabetes, obesity & metabolism·2026

Related Experiment Video

Updated: May 6, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.7K

Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management.

Joseph M Pappachan1, George I Varughese, Rajagopalan Sriraman

  • 1Joseph M Pappachan, George I Varughese, Department of Endocrinology, University Hospital of North Staffordshire, Stoke-on-Trent ST4 6QG, United Kingdom.

World Journal of Diabetes
|October 23, 2013
PubMed
Summary

Diabetic cardiomyopathy (DbCM) is an underappreciated cause of heart failure in diabetics. Early detection and management of DbCM are crucial for improving cardiovascular outcomes in patients with diabetes.

Keywords:
Cardiac autonomic neuropathyCoronary artery diseaseDiabetic cardiomyopathyHeart failureTransmitral Doppler Echocardiography

More Related Videos

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

758
Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

9.2K

Related Experiment Videos

Last Updated: May 6, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.7K
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

758
Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

9.2K

Area of Science:

  • Cardiology
  • Endocrinology
  • Pathophysiology

Background:

  • Cardiovascular disease is the leading cause of mortality in diabetic patients.
  • Diabetic cardiomyopathy (DbCM) is a significant, often overlooked, contributor to heart failure in diabetes.
  • The exact mechanisms driving DbCM are not fully understood but involve hyperglycemia, dyslipidemia, and inflammation.

Purpose of the Study:

  • To review the pathophysiology, diagnostic methods, and management strategies for diabetic cardiomyopathy.
  • To highlight the importance of early detection and comprehensive management of DbCM.

Main Methods:

  • Review of existing literature on diabetic cardiomyopathy.
  • Discussion of diagnostic tools including echocardiography and cardiac MRI.
  • Analysis of current and emerging treatment approaches.

Main Results:

  • DbCM is characterized by myocardial interstitial changes leading to diastolic and later systolic dysfunction.
  • Early diagnosis is possible with advanced imaging techniques like Tissue Doppler Imaging and Cardiac MRI.
  • Management includes lifestyle modifications, glycemic and lipid control, and treatment of comorbidities.

Conclusions:

  • Diabetic cardiomyopathy is a distinct clinical entity requiring specific attention in diabetic patients.
  • Integrated management strategies are essential for mitigating DbCM progression and improving patient prognosis.
  • Further research into novel therapeutic agents like antioxidants is warranted.